MRC Proof of Concept
MRC funding for academically led projects developing and testing novel therapeutics, medical devices, diagnostics and other healthcare interventions. Projects can span prototype development, preclinical testing and early clinical studies up to phase 2a. An eligible research organisation must lead; businesses may join as partners. There is no fixed funding cap. Stage one closes at 4:00pm UK time on 18 November 2026.
Next deadline
Date to be confirmed
What it funds
MRC funding for academically led projects developing and testing novel therapeutics, medical devices, diagnostics and other healthcare interventions. Projects can span prototype development, preclinical testing and early clinical studies up to phase 2a. An eligible research organisation must lead; businesses may join as partners. There is no fixed funding cap. Stage one closes at 4:00pm UK time on 18 November 2026.
Who it suits
Researchers with existing proof of concept data and a development plan for an intervention addressing a significant health need or a tool that improves intervention development
- Life sciences & health
- Feasibility
Programme specifications
Considering MRC Proof of Concept?
Talk through your project with a specialist and find out whether this is the right competition before you invest time in an application.